Overview
We deliver comprehensive genomic testing that helps clinicians diagnose diseases, monitor progression, and guide treatment decisions. Using advanced sequencing technologies and validated methodologies, the team supports patient care across prenatal medicine, rare genetic disorders, pharmacogenomics, and cancer genomics.
The testing portfolio
The laboratory offers genome and exome sequencing, targeted gene panels, familial testing, and comprehensive oncogenomic profiling. Whether identifying the cause of a rare genetic disorder, determining cancer treatment options through tumor profiling, or guiding medication choices through pharmacogenomics, the tests provide clinicians with the genetic information they need to personalize patient care.
Staying at the cutting edge
Genomic technology evolves rapidly. The laboratory continuously evaluates emerging methods and validates new testing approaches according to international guidelines, ensuring that proven innovations reach patients without compromising accuracy or reliability. This ongoing review process keeps the hospital's testing capabilities current as the field advances.
Speed when it matters
For critically ill patients, diagnostic delays can mean missed treatment windows. The laboratory's rapid genome and exome sequencing capabilities deliver results in time to influence clinical decisions, enabling physicians to move quickly from uncertainty to targeted intervention.
Centres & specialties